<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">evrazkar</journal-id><journal-title-group><journal-title xml:lang="ru">Евразийский Кардиологический Журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Eurasian heart journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2225-1685</issn><issn pub-type="epub">2305-0748</issn><publisher><publisher-name>Евразийская ассоциация кардиологов</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.38109/2225-1685-2020-2-34-40</article-id><article-id custom-type="elpub" pub-id-type="custom">evrazkar-6205</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL PAPERS</subject></subj-group></article-categories><title-group><article-title>ПРИВЕРЖЕННОСТЬ ЛЕЧЕНИЮ И КАЧЕСТВО ЖИЗНИ БОЛЬНЫХ СЕРДЕЧНО-СОСУДИСТЫМИ ЗАБОЛЕВАНИЯМИ НА АМБУЛАТОРНОМ ЭТАПЕ ОКАЗАНИЯ МЕДИЦИНСКОЙ ПОМОЩИ</article-title><trans-title-group xml:lang="en"><trans-title>ADHERENCE TO TREATMENT AND QUALITY OF LIFE OF PATIENTS WITH CARDIOVASCULAR DISEASES AT THE OUTPATIENT TREATMENT STAGE OF MEDICAL CARE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8070-2234</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кужелева</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuzheleva</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кужелева Елена Андреевна, к.м.н., научный сотрудник отделения патологии миокарда</p></bio><bio xml:lang="en"><p>Elena A. Kuzheleva, Candidate of Medical Sciences, Researcher, Department of Myocardial Pathology</p><p>Kievskaya, 111-A, Tomsk, 634012</p></bio><email xlink:type="simple">snigireva1209@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1437-8250</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Федюнина</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Fedyunina</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Федюнина Вера Александровна, младший научный сотрудник отделения патологии миокарда</p></bio><bio xml:lang="en"><p>Vera A. Fedyunina, Junior Researcher, Department of Myocardial Pathology</p></bio><email xlink:type="simple">veraaleksandrovna-1993@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9488-6900</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гарганеева</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Garganeeva</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гарганеева Алла Анатольевна, д.м.н., профессор, заведующая отделением патологии миокарда </p><p>тел.: + 7 (3822) 56-52-75</p></bio><bio xml:lang="en"><p>Alla A. Garganeeva, Doctor of Medical Sciences, Professor, Head of the Department of Myocardial Pathology</p><p>tel.: + 7 (3822) 56-52-75</p></bio><email xlink:type="simple">aag@cardio-tomsk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт кардиологии, Томский национальный исследовательский медицинский центр Российской академии наук (НИИ кардиологии Томского НИМЦ)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Cardiology Research Institute, Tomsk National Research Medical center, Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>30</day><month>06</month><year>2020</year></pub-date><volume>0</volume><issue>2</issue><fpage>34</fpage><lpage>40</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кужелева Е.А., Федюнина В.А., Гарганеева А.А., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Кужелева Е.А., Федюнина В.А., Гарганеева А.А.</copyright-holder><copyright-holder xml:lang="en">Kuzheleva E.A., Fedyunina V.A., Garganeeva A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.heartj.asia/jour/article/view/6205">https://www.heartj.asia/jour/article/view/6205</self-uri><abstract><sec><title>Цель</title><p>Цель: анализ приверженности лечению, факторов, влияющих на нее, и качества жизни больных сердечно-сосудистыми заболеваниями на амбулаторном этапе оказания медицинской помощи.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Численность исследуемой группы составила 225 человек. Для анализа приверженности пациентов лечению использовалась шкала комплаентности Мориски-Грина, а для оценки уровня КЖ жизни пациентов использовали международный опросник EuroQol EQ-5D-5L. Для получения индексов EQ-5D-5L использовали методологию пешеходного перехода Van Hout et al., а значения индекса получили из программы Crosswalk Index Value Calculator – EQ5D-5L. Статистическую обработку проводили с помощью программы STATISTICA 10.0.</p></sec><sec><title>Результаты</title><p>Результаты. Доля приверженных пациентов, обратившихся за амбулаторной медицинской помощью составила 59%. Основной причиной несоблюдения врачебных назначений была забывчивость – 25,27%. По мнению пациентов, в 73,8% случаев в повышении их комплаентности большую роль играет общение с врачом. Суммарный индекс КЖ пациентов с ССЗ составил 0,712 ± 0,165. При оценке взаимосвязи качества жизни и приверженности лечению, была выявлена положительная корреляция: чем более комплаентен пациент, чем выше его уровень качества жизни, и наоборот (r=0,2, p=0,013). Взаимосвязь между высокой приверженностью лечению и уровнем качества жизни подтверждалась в группе мужчин (p=0,01), тогда как у женщин статистическая значимость различий не достигалась (p=0,2). При анализе клинической картины ХСН, утяжеление ФК (с I на II) сопровождалось резким снижением самооценки здоровья для обоих полов (p=0,01).</p></sec><sec><title>Заключение</title><p>Заключение. Практически каждый второй пациент нарушает режим приема лекарственных препаратов. Улучшению приверженности лечению, может способствовать более пристальное внимание со стороны лечащего врача с подробным разъяснением причин и клинической картины заболевания, методов лечения, а также о способах самоконтроля симптомов заболевания. Степень приверженности лечению взаимосвязана с уровнем качества жизни по шкале EQ-5D-5L, преимущественно в мужской популяции.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim: to analyze an adherence to treatment, factors affecting it, and the quality of life of patients with cardiovascular diseases at the outpatient stage of medical care.</p></sec><sec><title>Material and methods</title><p>Material and methods. The population of the study was 225 people. The Moriski-green compliance scale was used to analyze patients’ adherence to treatment, and the EuroQol EQ-5D-5L international questionnaire was used to assess the quality of life of patients. Statistical data processing was performed using the program STATISTICA 10.0.</p></sec><sec><title>Results</title><p>Results. The percentage of committed to treating patients who sought outpatient care was 59%. The main reason for poor adherence was forgetfulness – 25,27 %. It is patient’s opinion, in 73.8% of cases, communication with a doctor plays an important role in improving their compliance. The total index of quality of life (QOL) of patients with cardiovascular diseases (CVD) was 0.712 ± 0.165. In estimating the relationship between quality of life and adherence to treatment, a positive correlation was found: the more compliant the patient, the higher their quality of life, and vice versa (r=0.2, p=0.013). The relationship between high adherence to treatment and quality of life was confirmed in the group of men (p=0.01), while the statistical significance of differences was not achieved in women (p=0.2). In examining the aspect of a disease of chronic heart failure (CHF), the worsening of NYHA functional class (from I to II) was accompanied by a sharp decrease in self-esteem of health for both sexes (p=0.01).</p></sec><sec><title>Conclusion</title><p>Conclusion. Almost every second patient is against of the rules of the medication regimen. Better adherence to treatment can be facilitated by more careful attention from the attending physician with a detailed explanation of the causes and the aspect of the disease, treatment methods, as well as ways to self-control the symptoms of the disease. The degree of treatment adherence is correlated with the level of quality of life on the EQ-5D-5L scale, mainly in the male population.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>приверженность лечению</kwd><kwd>качество жизни</kwd><kwd>EQ-5D5L</kwd><kwd>сердечно-сосудистые заболевания</kwd></kwd-group><kwd-group xml:lang="en"><kwd>adherence to treatment</kwd><kwd>quality of life</kwd><kwd>EQ-5D-5L</kwd><kwd>cardiovascular disease</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Федеральная служба государственной статистики: https://gks.ru/folder/12781/</mixed-citation><mixed-citation xml:lang="en">https://gks.ru/ folder/12781/ Federal State Statistics Service (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Бойцов С.А., Самородская И.В., Никулина Н.Н., и др. Сравнительный анализ смертности населения от острых форм ишемической болезни сердца за пятнадцатилетний период в РФ и США и факторов, влияющих на ее формирование. Терапевтический архив (архив до 2018 г.). 2017; 89(9):53-59. DOI: https://dx.doi.org/10.18565/pharmateca.2018.s3.85-87.</mixed-citation><mixed-citation xml:lang="en">Boytsov SA, Samorodskaya IV, Nikulina NN, et al. Comparative analysis of mortality from acute forms of coronary heart disease over a fifteen-year period in the Russian Federation and the USA and factors affecting its formation. Therapeutic Archive (archive until 2018) 2017;89(9): 53-59 (in Russ.). DOI: https://dx.doi.org/10.18565/pharmateca.2018.s3.85-87.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Sabate E. Adherence to long-term therapies: evidence for action. WHO. Geneva. 2003. P. 18.</mixed-citation><mixed-citation xml:lang="en">Sabate E. Adherence to long-term therapies: evidence for action. WHO. Geneva. 2003. P. 18.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">K. H. Leslie, C. McCowan, J. P. Pell. Adherence to cardiovascular medication: a review of systematic reviews. Journal of Public Health. 2018; 41 (1):84–94. doi.org/10.1093/pubmed/fdy088</mixed-citation><mixed-citation xml:lang="en">K. H. Leslie, C. McCowan, J. P. Pell. Adherence to cardiovascular medication: a review of systematic reviews. Journal of Public Health. 2018; 41 (1):84–94. doi.org/10.1093/pubmed/fdy088</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Кужелева Е. А., Борель К. Н., Гарганеева А. А. Низкая приверженность лечению после перенесенного инфаркта миокарда: причины и способы коррекции с учетом психоэмоционального состояния пациентов. Рациональная фармакотерапия в кардиологии. 2016;12(3): 291-295. DOI: http://dx.doi.org/10.20996/1819-6446-2016-12- 3-291-295.</mixed-citation><mixed-citation xml:lang="en">Kuzheleva E. A., Borel K. N., Garganeeva A. A. Low adherence to treatment after myocardial infarction: causes and methods of correction taking into account the psychoemotional state of patients. Rational pharmacotherapy in cardiology 2016; 12 (3): 291- 295 (in Russ.). DOI: http://dx.doi.org/10.20996/1819-6446-2016-12- 3-291-295.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Одинцова В. В., Зудин А. Б., Горчакова Н. М., и др. Качество жизни и жизни и благополучие пациентов с хроническими заболеваниями. М.: Методические рекомендации (№ 5), 2016. 3 с.</mixed-citation><mixed-citation xml:lang="en">Odintsova V. V., Zudin A. B., Gorchakova N. M., et al. Quality of life and life and well-being of patients with chronic diseases. M.: Guidelines (No. 5) 2016. P. 3. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Баланова Ю.А., Концевая А.В., Шальнова С.А., и др. Качество жизни лиц с артериальной гипертензией в России - есть ли связь со статусом лечения (по данным популяционного исследования ЭССЕ - РФ). Российский кардиологический журнал 2016; (9):7-13. DOI: https://doi.org/10.15829/1560-4071-2016-9-7-13.</mixed-citation><mixed-citation xml:lang="en">Balanova Yu.A., Kontsevaya A.V., Shalnova S.A., et al. Quality of life of people with arterial hypertension in Russia - is there any connection with the status of treatment (according to the population study ESSE - RF). Russian Journal of Cardiology 2016; (9): 7-13 (in Russ.). DOI: https://doi.org/10.15829/1560-4071-2016-9-7-13.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mandy van Reenen, Mark Oppe, Kristina Secnik Boye, et. All. EQ-5D User Guide Basic information on how to use the EQ-5D – 5L instrument. Version 3.0. 2019. P. 1 - 36.</mixed-citation><mixed-citation xml:lang="en">Mandy van Reenen, Mark Oppe, Kristina Secnik Boye, et. All. EQ-5D User Guide Basic information on how to use the EQ-5D – 5L instrument. Version 3.0. 2019. P. 1 - 36.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Herdman М. et al. Qual Life Res. Interim scoring for the THE EQ-5D-5L: Mapping the EQ-5D-5L TO EQ-5D-3L value sets. P. 1 - 3.</mixed-citation><mixed-citation xml:lang="en">Herdman М. et al. Qual Life Res. Interim scoring for the THE EQ-5D-5L: Mapping the EQ-5D-5L TO EQ-5D-3L value sets. P. 1 - 3.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Концевая А. В., Шальнова С. А., Баланова Ю. А. и др. Качество жизни российской популяции по данным исследования ЭССЕ-РФ. Кардиоваскулярная терапия и профилактика 2016; 15(5): 84 - 90. DOI:https://doi.org/10.15829/1728-8800-2016-5-84-90</mixed-citation><mixed-citation xml:lang="en">Kontsevaya A. V., Shalnova S. A., Balanova Yu. A. et al. The quality of life of the Russian population according to an ESSE-RF study. Cardiovascular Therapy and Prevention. 2016;15(5):84-90 (in Russ.). DOI:https://doi.org/10.15829/1728-8800-2016-5-84-90</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care. 1986; 24(1): 67-74.</mixed-citation><mixed-citation xml:lang="en">Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care. 1986; 24(1): 67-74.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Лукина Ю.В., Гинзбург М.Л., Смирнов В.П. и др. Приверженность лечению, предшествующему госпитализации, у пациентов с острым коронарным синдромом. Клиницист. 2012; 2: 41-9.</mixed-citation><mixed-citation xml:lang="en">Lukina Yu.V., Ginzburg M.L., Smirnov V.P., et al. Adherence to treatment prior to hospitalization in patients with acute coronary syndrome. Clinician. 2012; 2: 41-9 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Акулова А. И., Гайдукова И. З., Ребров А. П. Валидация версии 5L опросника EQ-5D в России. Научно-практическая ревматология 2018; 56(3): 351-355. DOI: https://doi.org/10.14412/1995-4484-2018-351-355.</mixed-citation><mixed-citation xml:lang="en">Akulova A.I., Gaidukova I.Z., Rebrov A.P. Validation of version 5L of the EQ-5D questionnaire in Russia. Scientific and Practical Rheumatology. 2018; 56 (3): 351-355 (in Russ.). DOI: https://doi.org/10.14412/1995-4484-2018-351-355.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Shaw J.W., Johnson J.A., Coons S.J. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005; 43(3): 203-20. DOI: 10.1097/00005650-200503000-00003</mixed-citation><mixed-citation xml:lang="en">Shaw J.W., Johnson J.A., Coons S.J. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005; 43(3): 203-20. DOI: 10.1097/00005650-200503000-00003</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ben van Hout, M.F. Janssen, You-Shan Feng, et. al. Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets. Value in Health. 2012; 15: 708 –715. DOI: doi:10.1016/j.jval.2012.02.008</mixed-citation><mixed-citation xml:lang="en">Ben van Hout, M.F. Janssen, You-Shan Feng, et. al. Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets. Value in Health. 2012; 15: 708 –715. DOI: doi:10.1016/j.jval.2012.02.008</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Crosswalk Index Value Calculator – EQ-5D-5L: https://euroqol.org/ eq-5d-instruments/eq-5d-5l-about/valuation-standard-value-sets/ crosswalk-index-value-calculator/</mixed-citation><mixed-citation xml:lang="en">Crosswalk Index Value Calculator – EQ-5D-5L: https://euroqol.org/ eq-5d-instruments/eq-5d-5l-about/valuation-standard-value-sets/ crosswalk-index-value-calculator/</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Погосова Г.В., Колтунов И.Е., Мелик-Оганджанян Г.Ю., и др. Приверженность лечению сердечно-сосудистых заболеваний: проблема врачей и пациентов. Кардиоваскулярная терапия и профилактика. 2009;8(4):98-102.</mixed-citation><mixed-citation xml:lang="en">Pogosova G.V., Koltunov I.E., Melik-Oganjanjan G.Yu., et al. Adherence to the treatment of cardiovascular disease: a problem for doctors and patients. Cardiovascular therapy and prevention. 2009; 8 (4): 98-102 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Cesar I. Fernandez-Lazaro, Juan M. García-González, David P. Adams, et al. Adherence to treatment and related factors among patients with chronic conditions in primary care: a cross-sectional study. BMC Family Practice, 2019; 20 (132): 1 – 12. doi.org/10.1186/s12875-019- 1019-3.</mixed-citation><mixed-citation xml:lang="en">Cesar I. Fernandez-Lazaro, Juan M. García-González, David P. Adams, et al. Adherence to treatment and related factors among patients with chronic conditions in primary care: a cross-sectional study. BMC Family Practice, 2019; 20 (132): 1 – 12. doi.org/10.1186/s12875-019- 1019-3.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao Ni, Latefa Dardas, Bei Wu, et. al. Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review. Heart Asia. 2019; 11(2): 1 – 2. doi: 10.1136/ heartasia-2018-011173.</mixed-citation><mixed-citation xml:lang="en">Zhao Ni, Latefa Dardas, Bei Wu, et. al. Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review. Heart Asia. 2019; 11(2): 1 – 2. doi: 10.1136/ heartasia-2018-011173.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Van der Laan, Danielle M, Christel C. L., et. al. Factors Associated with Nonadherence to Cardiovascular Medications. Journal of Cardiovascular Nursin. 2019; 34 (4): 344–352. doi: 10.1097/ JCN.0000000000000582.</mixed-citation><mixed-citation xml:lang="en">Van der Laan, Danielle M, Christel C. L., et. al. Factors Associated with Nonadherence to Cardiovascular Medications. Journal of Cardiovascular Nursin. 2019; 34 (4): 344–352. doi: 10.1097/ JCN.0000000000000582.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Khayyat SM, Mohamed MMA, Khayyat SMS, et al. Association between medication adherence and quality of life of patients with diabetes and hypertension attending primary care clinics: a crosssectional survey. Qual Life Res. 2019;28(4): 1053-1061. doi: 10.1007/ s11136-018-2060-8.</mixed-citation><mixed-citation xml:lang="en">Khayyat SM, Mohamed MMA, Khayyat SMS, et al. Association between medication adherence and quality of life of patients with diabetes and hypertension attending primary care clinics: a crosssectional survey. Qual Life Res. 2019;28(4): 1053-1061. doi: 10.1007/ s11136-018-2060-8.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Дворецкий Л.И., Гибрадзе Н.Т., Черкасова Н.А., др. Ишемическая болезнь сердца у женщин. Русский медицинский журнал. 2011; 2: 79.</mixed-citation><mixed-citation xml:lang="en">Butler LI, Gibradze NT, Cherkasova NA, et al. Coronary heart disease in women. Russian Medical Journal. 2011; 2: 79 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Voratima Silavanich, Surakit Nathisuwan, Arintaya Phrommintikul et. al. Relationship of medication adherence and quality of life among heart failure patients. Heart &amp; Lung. 2018; 1: 1 – 6. doi.org/10.1016/j. hrtlng.2018.09.009.</mixed-citation><mixed-citation xml:lang="en">Voratima Silavanich, Surakit Nathisuwan, Arintaya Phrommintikul et. al. Relationship of medication adherence and quality of life among heart failure patients. Heart &amp; Lung. 2018; 1: 1 – 6. doi.org/10.1016/j. hrtlng.2018.09.009.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Вологдина И. В., Симаненков В. И, Порошина Е. Г. Качество жизни и приверженность терапии у пациентов пожилого и старческого возраста с хронической сердечной недостаточностью, коморбидными когнитивными и аффективными нарушениями. Вестник Северо-Западного государственного медицинского университета им. И.И. Мечникова. 2016; 8 (1): 45–49.</mixed-citation><mixed-citation xml:lang="en">Vologdina I.V., Simanenkov V.I., Poroshina E.G. Quality of life and adherence to therapy in elderly patients with chronic heart failure, comorbid cognitive and affective disorders. Bulletin of the North-West State Medical University. I.I. Mechnikov. 2016; 8 (1): 45–49 (in Russ.).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
